Clinical trials
Leukemia trials with no applicable phase and unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique Hopitaux De Marseille | 3 |
| Federal University of Health Science of Porto Alegre | 2 |
| Alberta Health Services, Calgary | 1 |
| Beijing Immunochina Medical Science & Technology Co., Ltd. | 1 |
| Blue Note Therapeutics | 1 |
| CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 1 |
| Children's Cancer and Leukaemia Group | 1 |
| Daniel Godoy Martinez | 1 |
| Dutch Childhood Oncology Group | 1 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 32 |
| Lymphoma | 13 |
| Neoplasms | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Graft vs Host Disease | 4 |
| Hematologic Neoplasms | 4 |
| Multiple Myeloma | 4 |
| Congenital Abnormalities | 3 |
| Leukemia, Myeloid, Acute | 3 |
| Neoplasms, Plasma Cell | 3 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.